HYUNDAI BIOLAND (Korea) Performance
| 052260 Stock | KRW 4,250 125.00 2.86% |
The company retains a Market Volatility (i.e., Beta) of 0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, HYUNDAI BIOLAND's returns are expected to increase less than the market. However, during the bear market, the loss of holding HYUNDAI BIOLAND is expected to be smaller as well. At this point, HYUNDAI BIOLAND CoLtd has a negative expected return of -0.39%. Please make sure to check out HYUNDAI BIOLAND's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if HYUNDAI BIOLAND CoLtd performance from the past will be repeated at some future point.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days HYUNDAI BIOLAND CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -2.2 B |
HYUNDAI |
HYUNDAI BIOLAND Relative Risk vs. Return Landscape
If you would invest 546,000 in HYUNDAI BIOLAND CoLtd on September 1, 2024 and sell it today you would lose (121,000) from holding HYUNDAI BIOLAND CoLtd or give up 22.16% of portfolio value over 90 days. HYUNDAI BIOLAND CoLtd is generating negative expected returns and assumes 2.4746% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than HYUNDAI, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HYUNDAI BIOLAND Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HYUNDAI BIOLAND's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HYUNDAI BIOLAND CoLtd, and traders can use it to determine the average amount a HYUNDAI BIOLAND's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1561
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 052260 |
Estimated Market Risk
| 2.47 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average HYUNDAI BIOLAND is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HYUNDAI BIOLAND by adding HYUNDAI BIOLAND to a well-diversified portfolio.
HYUNDAI BIOLAND Fundamentals Growth
HYUNDAI Stock prices reflect investors' perceptions of the future prospects and financial health of HYUNDAI BIOLAND, and HYUNDAI BIOLAND fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HYUNDAI Stock performance.
| Return On Equity | -6.61 | |||
| Return On Asset | -0.0024 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 347.91 B | |||
| Shares Outstanding | 15 M | |||
| Price To Earning | 34.17 X | |||
| Price To Sales | 1.75 X | |||
| Revenue | 102.8 B | |||
| EBITDA | 6.98 B | |||
| Cash And Equivalents | 260 | |||
| Cash Per Share | 860.30 X | |||
| Total Debt | 217.62 M | |||
| Debt To Equity | 0.31 % | |||
| Cash Flow From Operations | 21.48 B | |||
| Total Asset | 172.74 B | |||
| Retained Earnings | 93.7 B | |||
| Current Asset | 64.74 B | |||
| Current Liabilities | 28 B | |||
About HYUNDAI BIOLAND Performance
By analyzing HYUNDAI BIOLAND's fundamental ratios, stakeholders can gain valuable insights into HYUNDAI BIOLAND's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HYUNDAI BIOLAND has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HYUNDAI BIOLAND has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
,Ltd manufactures and sells raw materials for cosmetics, and food and pharmaceuticals. ,Ltd was founded in 1995 and is based in Cheongju, South Korea. HYUNDAI BIOLAND is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about HYUNDAI BIOLAND CoLtd performance evaluation
Checking the ongoing alerts about HYUNDAI BIOLAND for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HYUNDAI BIOLAND CoLtd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HYUNDAI BIOLAND generated a negative expected return over the last 90 days | |
| The company reported the revenue of 102.8 B. Net Loss for the year was (11.69 B) with profit before overhead, payroll, taxes, and interest of 17.13 B. | |
| About 34.0% of the company shares are owned by insiders or employees |
- Analyzing HYUNDAI BIOLAND's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HYUNDAI BIOLAND's stock is overvalued or undervalued compared to its peers.
- Examining HYUNDAI BIOLAND's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HYUNDAI BIOLAND's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HYUNDAI BIOLAND's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HYUNDAI BIOLAND's stock. These opinions can provide insight into HYUNDAI BIOLAND's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HYUNDAI Stock analysis
When running HYUNDAI BIOLAND's price analysis, check to measure HYUNDAI BIOLAND's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HYUNDAI BIOLAND is operating at the current time. Most of HYUNDAI BIOLAND's value examination focuses on studying past and present price action to predict the probability of HYUNDAI BIOLAND's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HYUNDAI BIOLAND's price. Additionally, you may evaluate how the addition of HYUNDAI BIOLAND to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |